使用安捷伦片段分析仪系统分析IVT mRNA的最佳实践 - 生物工艺在线
Best Practices For Analysis Of IVT mRNA Using The Agilent Fragment Analyzer Systems - Bioprocess Online
生物技术与制药领域的最新动态
Best Practices For Analysis Of IVT mRNA Using The Agilent Fragment Analyzer Systems - Bioprocess Online
Earnings Snapshot: Agilent Technologies guides FY26 above estimates after FQ4 double-beat - Seeking Alpha
Top Stock Reports for Alphabet, Roche & RTX - Nasdaq
Agilent stock edges lower post Q4 print By Investing.com - Investing.com South Africa
Agilent Technologies earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com Nigeria
Agilent: Fiscal Q4 Earnings Snapshot - MarketScreener
Agilent (A) Exceeds Revenue Expectations with Strong Q4 Performa - GuruFocus
Agilent Technologies (A) Projects FY26 Revenue to Reach Up to $7 - GuruFocus
Agilent Technologies earnings beat by $0.01, revenue topped estimates - Investing.com
Earnings Flash (A) Agilent Technologies, Inc. Reports Q4 Revenue $1.86B, vs. FactSet Est of $1.83B - MarketScreener
Earnings Flash (A) Agilent Technologies, Inc. Posts Q4 Adjusted EPS $1.59 per Share, vs. FactSet Est of $1.58 - MarketScreener
Agilent Technologies Reports Fourth-Quarter Fiscal Year 2025 Financial Results - TradingView
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Bakersfield.com
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results - Business Wire
Agilent beats quarterly revenue estimates on strong demand for lab tools - MarketScreener
FDA's Pazdur is said to raise questions about commissioners actions, new voucher
UK-US drug pricing deal could come as early as this week, sources say
#ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins
Roche expands Veeva partnership with AI-enabled CRM adoption By Investing.com - Investing.com Australia
Agilent (A) Set to Announce Earnings with Consensus Estimate - GuruFocus